Buyer beware: inflated claims of sensitivity for rapid COVID-19 tests.
作者信息
Fitzpatrick Meagan C, Pandey Abhishek, Wells Chad R, Sah Pratha, Galvani Alison P
机构信息
Center for Vaccine Development and Global Health, University of Maryland School of Medicine, University of Maryland, Baltimore, MD, USA; Center for Infectious Disease Modeling and Analysis, Yale School of Public Health, Yale University, New Haven, CT 06520, USA.
Center for Infectious Disease Modeling and Analysis, Yale School of Public Health, Yale University, New Haven, CT 06520, USA.
出版信息
Lancet. 2021 Jan 2;397(10268):24-25. doi: 10.1016/S0140-6736(20)32635-0. Epub 2020 Dec 14.
Abstract
摘要
相似文献
1
Buyer beware: inflated claims of sensitivity for rapid COVID-19 tests.买家需谨慎：新冠病毒快速检测的敏感度存在夸大宣传。
Lancet. 2021 Jan 2;397(10268):24-25. doi: 10.1016/S0140-6736(20)32635-0. Epub 2020 Dec 14.
2
Saliva Tests Comparable With Nasal Swabs for SARS-CoV-2 Detection.唾液检测在检测新冠病毒方面与鼻拭子相当。
JAMA. 2021 Mar 9;325(10):924. doi: 10.1001/jama.2021.1780.
3
Strengths and weakness of diagnostic tests of SARS CoV-2 infection.新型冠状病毒2019感染诊断检测方法的优缺点
Med Clin (Barc). 2020 Nov 27;155(10):464-465. doi: 10.1016/j.medcli.2020.05.019. Epub 2020 Jun 5.
4
Saliva-based testing for diagnosis of SARS-CoV-2 infection: A meta-analysis.基于唾液检测诊断新型冠状病毒2019感染：一项荟萃分析。
J Med Virol. 2021 Mar;93(3):1256-1258. doi: 10.1002/jmv.26613. Epub 2020 Nov 10.
5
Combined Self-Collected Anterior Nasal and Oropharyngeal Specimens versus Provider-Collected Nasopharyngeal Swabs for the Detection of SARS-CoV-2.联合自我采集的前鼻拭子和口咽拭子与医护人员采集的鼻咽拭子用于检测严重急性呼吸综合征冠状病毒2
J Clin Microbiol. 2020 Dec 17;59(1). doi: 10.1128/JCM.02291-20.
6
[SARS-CoV-2 Testing in Cadavers: The Experience of the Southern Portugal Delegation of the National Institute of Forensic Medicine and Forensic Sciences].[尸体中的新型冠状病毒检测：葡萄牙国家法医学和法医学科学研究所南葡萄牙代表团的经验]
Acta Med Port. 2020 Dec 2;33(12):858. doi: 10.20344/amp.15216.
7
How to use imperfect tests for COVID-19 (SARS-CoV-2) to make clinical decisions.如何利用针对2019冠状病毒病（严重急性呼吸综合征冠状病毒2）的不完善检测来做出临床决策。
Med J Aust. 2021 Feb;214(2):69-73.e1. doi: 10.5694/mja2.50907. Epub 2021 Jan 7.
8
SARS-CoV-2 diagnostics: Some reflections on current assays.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）诊断：关于当前检测方法的一些思考。
Diagn Microbiol Infect Dis. 2021 Feb;99(2):115237. doi: 10.1016/j.diagmicrobio.2020.115237. Epub 2020 Oct 7.
9
Comparison of 4 molecular assays for detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).用于检测严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的4种分子检测方法的比较
Diagn Microbiol Infect Dis. 2021 Feb;99(2):115196. doi: 10.1016/j.diagmicrobio.2020.115196. Epub 2020 Oct 17.
10
Mass testing for covid-19 in the UK.英国针对新冠病毒的大规模检测。
BMJ. 2020 Nov 16;371:m4436. doi: 10.1136/bmj.m4436.
引用本文的文献
1
Natural frequency tree- versus conditional probability formula-based training for medical students' estimation of screening test predictive values: a randomized controlled trial.基于自然频率树与条件概率公式的医学生预测值估算培训：一项随机对照试验。
BMC Med Educ. 2024 Oct 24;24(1):1207. doi: 10.1186/s12909-024-06209-0.
2
In search of COVID-19: The ability of biodetection canines to detect COVID-19 odours from clinical samples.寻找新冠病毒：生物检测犬从临床样本中检测新冠病毒气味的能力。
J Assoc Med Microbiol Infect Dis Can. 2022 Nov 29;7(4):343-349. doi: 10.3138/jammi-2022-0017. eCollection 2022 Nov.
3
Evolution of the newest diagnostic methods for COVID-19: a Chinese perspective.新冠病毒最新诊断方法的演变：中国视角。
J Zhejiang Univ Sci B. 2023 Jun 15;24(6):463-484. doi: 10.1631/jzus.B2200625.
4
CovMS: An Automated and Quantitative Matrix-Independent Assay for Mass Spectrometric Measurement of SARS-CoV-2 Nucleocapsid Protein.CovMS：一种自动化和定量的基质独立测定法，用于质谱法测量 SARS-CoV-2 核衣壳蛋白。
Anal Chem. 2022 Dec 20;94(50):17379-17387. doi: 10.1021/acs.analchem.2c01610. Epub 2022 Dec 9.
5
The Coronavirus Standards Working Group's roadmap for improved population testing.冠状病毒标准工作组关于改进人群检测的路线图。
Nat Biotechnol. 2022 Nov;40(11):1563-1568. doi: 10.1038/s41587-022-01538-1.
6
Modeling the optimization of COVID-19 pooled testing: How many samples can be included in a single test?新冠病毒混合检测优化建模：一次检测可包含多少个样本？
Inform Med Unlocked. 2022;32:101037. doi: 10.1016/j.imu.2022.101037. Epub 2022 Aug 7.
7
Symptoms and risk factors for hospitalization of COVID-19 presented in primary care : An exploratory retrospective study.在基层医疗中出现的 COVID-19 住院症状和危险因素：一项探索性回顾性研究。
Wien Klin Wochenschr. 2022 May;134(9-10):335-343. doi: 10.1007/s00508-021-01992-y. Epub 2022 Feb 11.
8
Diagnostic accuracy of a rapid diagnostic test for the early detection of COVID-19.用于早期检测 COVID-19 的快速诊断检测的诊断准确性。
J Clin Virol. 2022 Feb;147:105023. doi: 10.1016/j.jcv.2021.105023. Epub 2021 Oct 28.
9
Implementation and Accuracy of BinaxNOW Rapid Antigen COVID-19 Test in Asymptomatic and Symptomatic Populations in a High-Volume Self-Referred Testing Site.高流量自我转诊检测点中无症状和有症状人群中 BinaxNOW 快速抗原 COVID-19 检测的实施和准确性。
Microbiol Spectr. 2021 Dec 22;9(3):e0100821. doi: 10.1128/Spectrum.01008-21. Epub 2021 Dec 1.
10
A Telemedicine-Guided Self-Collection Approach for PCR-Based SARS-CoV-2 Testing: Comparative Study.一种用于基于PCR的SARS-CoV-2检测的远程医疗指导下的自我采样方法：比较研究
JMIR Form Res. 2022 Jan 4;6(1):e32564. doi: 10.2196/32564.
本文引用的文献
1
Clinical sensitivity and interpretation of PCR and serological COVID-19 diagnostics for patients presenting to the hospital.临床灵敏度和对住院患者的 PCR 和血清学 COVID-19 诊断的解读。
FASEB J. 2020 Oct;34(10):13877-13884. doi: 10.1096/fj.202001700RR. Epub 2020 Aug 28.
2
Rapid Scaling Up of Covid-19 Diagnostic Testing in the United States - The NIH RADx Initiative.美国快速扩大新冠病毒诊断检测规模——美国国立卫生研究院加速诊断计划
N Engl J Med. 2020 Sep 10;383(11):1071-1077. doi: 10.1056/NEJMsr2022263. Epub 2020 Jul 22.
3
The implications of silent transmission for the control of COVID-19 outbreaks.静默传播对控制 COVID-19 疫情的影响。
Proc Natl Acad Sci U S A. 2020 Jul 28;117(30):17513-17515. doi: 10.1073/pnas.2008373117. Epub 2020 Jul 6.
Zotero 插件